Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22140362.
- Also identified by DOI 10.1371/journal.pmed.1001127 and PMC identifier 3226452.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Scaling up voluntary medical male circumcision (VMMC) for HIV prevention is cost saving and creates fiscal space in the future that otherwise would have been encumbered by antiretroviral treatment costs. An investment of US$1,500,000,000 between 2011 and 2015 to achieve 80% coverage in 13 priority countries in southern and eastern Africa will result in net savings of US$16,500,000,000. Strong political leadership, country ownership, and stakeholder engagement, along with effective demand creation, community mobilisation, and human resource deployment, are essential. This collection of articles on determining the cost and impact of VMMC for HIV prevention signposts the way forward to scaling up VMMC service delivery safely and efficiently to reap individual- and population-level benefits.
Medical subject headings
- Circumcision, Male
- HIV Infections
- Health Care Costs
- Health Promotion
- Preventive Health Services